It's been nearly a year since chipmaker Intel named Brian Krzanich as its new CEO, and in that time, the troubles it faces haven't changed.
Coke reported better-than-expected quarterly revenue, as strong sales in China offset sluggish Europe and U.S. volumes.
Johnson & Johnson reported quarterly earnings and revenue that beat analysts' expectations on Tuesday.
Swiss pharmaceuticals company Roche posted a rise in first-quarter sales but failed to meet market expectations as a strong Swiss franc hit results.
Get the best of CNBC in your inbox